These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32697644)

  • 1. Review of normal gastrointestinal tract, ulcerative colitis, proctitis and rectal medication adherence.
    Naeck-Boolauky P; Adio J; Burch J
    Br J Nurs; 2020 Jul; 29(14):805-811. PubMed ID: 32697644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository.
    Kato S; Ishibashi A; Kani K; Yakabi K
    Digestion; 2018; 97(1):59-63. PubMed ID: 29393142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment for ulcerative proctitis with rectal tacrolimus in an 8-year-old girl with intolerance to mesalamine.
    Navas-López VM; Blasco-Alonso J; Girón Fernández-Crehuet F; Serrano Nieto MJ; Gallego-Gutiérrez S; Luque Pérez S; Sierra Salinas C
    Clin J Gastroenterol; 2014 Aug; 7(4):320-3. PubMed ID: 26185880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis.
    Yoshimatsu Y; Naganuma M; Sugimoto S; Tanemoto S; Umeda S; Fukuda T; Nomura E; Yoshida K; Ono K; Mutaguchi M; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Takabayashi K; Ogata H; Iwao Y; Kanai T
    Digestion; 2020; 101(4):492-498. PubMed ID: 31238326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical therapy is underused in patients with ulcerative colitis.
    Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
    J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM; Kushkuley S; Barrett JA; Oster G
    Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
    Kruis W; Neshta V; Pesegova M; Alekseeva O; Andreev P; Datsenko O; Levchenko O; Abdulkhakov S; Lozynskyy Y; Mostovoy Y; Soloviev K; Dorofeyev AE; Vieth M; Stiess M; Greinwald R; Mohrbacher R; Siegmund B
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):98-106.e4. PubMed ID: 29702300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active and refractory ulcerative proctitis: an update].
    Caselli M G; Pinedo M G; Zúñiga D A; Alvarez L M
    Rev Med Chil; 2010 Jan; 138(1):109-16. PubMed ID: 20361160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical agents for idiopathic distal colitis and proctitis.
    Lawrance IC
    J Gastroenterol Hepatol; 2011 Jan; 26(1):36-43. PubMed ID: 21175791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic requirements in active ulcerative proctitis: A single-centre study.
    Calafat M; Lobatón T; Mañosa M; Marín L; Caballero N; Larraín M; Cabré E; Domènech E
    Gastroenterol Hepatol; 2017 Dec; 40(10):663-668. PubMed ID: 28666605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.
    Regueiro M; Loftus EV; Steinhart AH; Cohen RD;
    Inflamm Bowel Dis; 2006 Oct; 12(10):972-8. PubMed ID: 17012968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative proctitis: a review of pharmacotherapy and management.
    Lakatos PL; Lakatos L
    Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of severe inflammatory disease of the rectum and distal colon: non-nutritional aspects.
    Polson RJ; Misiewicz JJ
    Baillieres Clin Gastroenterol; 1992 Mar; 6(1):1-26. PubMed ID: 1586763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease.
    Kiely CJ; Clark A; Bhattacharyya J; Moran GW; Lee JC; Parkes M
    Dig Dis Sci; 2018 Apr; 63(4):1011-1015. PubMed ID: 29457211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative proctitis: an update on the pharmacotherapy and management.
    Gecse KB; Lakatos PL
    Expert Opin Pharmacother; 2014 Aug; 15(11):1565-73. PubMed ID: 24837209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review and update on ulcerative colitis
    Gajendran M; Loganathan P; Jimenez G; Catinella AP; Ng N; Umapathy C; Ziade N; Hashash JG
    Dis Mon; 2019 Dec; 65(12):100851. PubMed ID: 30837080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.
    Christophi GP; Rengarajan A; Ciorba MA
    Clin Exp Gastroenterol; 2016; 9():125-30. PubMed ID: 27274301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis.
    Stobaugh DJ; Deepak P; Thorpe M; Hannon B; Ehrenpreis ED
    Inflamm Bowel Dis; 2013 Feb; 19(2):301-8. PubMed ID: 22644716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.